16
Participants
Start Date
December 19, 2014
Primary Completion Date
March 4, 2016
Study Completion Date
March 4, 2016
BP-C1
BP-C1, 0.05% solution for injections; doses: 0.035 mg/kg body weight (0.07 mL/kg) intramuscularly once daily for 32 consecutive days
BP-C2
BP-C2, 0.15% solution for oral use; 15 ml orally once daily for 32 consecutive days
National Liver Institute, Menoufia University, Cairo
Lead Sponsor
Collaborators (1)
Meddoc
OTHER
Norwegian University of Life Sciences
OTHER
Meabco A/S
INDUSTRY